Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
06 2020
Historique:
entrez: 26 6 2020
pubmed: 26 6 2020
medline: 3 7 2020
Statut: ppublish

Résumé

We evaluated SARS-CoV-2 RNA and neutralising antibodies in blood donors (BD) residing in the Lodi Red Zone, Italy. Of 390 BDs recruited after 20 February 2020 - when the first COVID-19 case in Lombardy was identified, 91 (23%) aged 19-70 years were antibody positive. Viral RNA was detected in an additional 17 (4.3%) BDs, yielding ca 28% (108/390) with evidence of virus exposure. Five stored samples collected as early as 12 February were seropositive.

Identifiants

pubmed: 32583766
doi: 10.2807/1560-7917.ES.2020.25.24.2001031
pmc: PMC7315724
doi:

Substances chimiques

Antibodies, Neutralizing 0
COVID-19 Vaccines 0
Covid-19 aAPC vaccine 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn
Type : ErratumIn

Références

J Clin Invest. 2020 Jun 1;130(6):2757-2765
pubmed: 32254064
J Med Virol. 2020 Apr 15;:
pubmed: 32293713
J Med Virol. 2020 Apr 13;:
pubmed: 32281679
Vox Sang. 2020 Apr 2;:
pubmed: 32240545
JAMA. 2020 Mar 17;:
pubmed: 32181795
J Korean Med Sci. 2020 Apr 13;35(14):e149
pubmed: 32281317
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496
pubmed: 32253318
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
J Clin Virol. 2020 Jun;127:104358
pubmed: 32305026
Viruses. 2020 Jan 29;12(2):
pubmed: 32013152

Auteurs

Elena Percivalle (E)

Molecular Virology Unit, Microbiology and Virology Department, IRCCS Policlinico San Matteo, Pavia, Italy.

Giuseppe Cambiè (G)

Immunohematology and Transfusion Medicine Unit, Ospedale Maggiore di Lodi, Lodi, Italy.

Irene Cassaniti (I)

Molecular Virology Unit, Microbiology and Virology Department, IRCCS Policlinico San Matteo, Pavia, Italy.
Department of Clinical Surgical Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.

Edoardo Vecchio Nepita (EV)

Molecular Virology Unit, Microbiology and Virology Department, IRCCS Policlinico San Matteo, Pavia, Italy.
Department of Clinical Surgical Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.

Roberta Maserati (R)

Molecular Virology Unit, Microbiology and Virology Department, IRCCS Policlinico San Matteo, Pavia, Italy.

Alessandro Ferrari (A)

Molecular Virology Unit, Microbiology and Virology Department, IRCCS Policlinico San Matteo, Pavia, Italy.
Department of Clinical Surgical Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.

Raffaella Di Martino (R)

Molecular Virology Unit, Microbiology and Virology Department, IRCCS Policlinico San Matteo, Pavia, Italy.
Department of Clinical Surgical Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.

Paola Isernia (P)

SIMT, Centro Lavorazione e Validazione, IRCCS Policlinico San Matteo, Pavia, Italy.

Francesco Mojoli (F)

Department of Clinical Surgical Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
ICU1 Department of Intensive Medicine, IRCCS Policlinico San Matteo, Pavia, Italy.

Raffaele Bruno (R)

Department of Clinical Surgical Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
Infectious Diseases I, Department of Medical Sciences and Infectious Diseases, IRCCS Policlinico San Matteo, Pavia, Italy.

Marcello Tirani (M)

Health Protection Agency of Pavia, Department of Hygiene and Preventive Medicine, Pavia, Italy.
Lombardy Region, Directorate General for Health, UO Prevenzione, Milan, Italy.

Danilo Cereda (D)

Lombardy Region, Directorate General for Health, UO Prevenzione, Milan, Italy.

Carlo Nicora (C)

Chief Executive Office, IRCCS Policlinico San Matteo, Pavia, Italy.

Massimo Lombardo (M)

Chief Executive Office, ASST Lodi, Lodi, Italy.

Fausto Baldanti (F)

Molecular Virology Unit, Microbiology and Virology Department, IRCCS Policlinico San Matteo, Pavia, Italy.
Department of Clinical Surgical Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH